Congrats to the Iambic team on the preview launch of NeuralPLexer3 Beta! This next-gen #AI model redefines #DrugDiscovery with rapid, high-precision protein-ligand predictions. Researchers now have a valuable tool to accelerate therapeutic exploration across diverse protein classes, moving past traditional roadblocks in structure-based design. #PartnerNews
Today we are previewing our next-generation NeuralPLexer3 Beta AI model, which sets new standards for protein-ligand structure prediction – transforming structure determination from a bottleneck into a truly interactive tool for drug discovery. NeuralPLexer3 Beta enables researchers to explore therapeutic hypotheses with unprecedented accuracy and speed. Trained on datasets encompassing a vast array of biologic structures and interaction types, the new model provides researchers instant, accurate structural insights across the full range of protein classes and drug molecules. This next version of NeuralPLexer is a significant step toward fully AI-enabled structure-based drug design. Learn more here: https://lnkd.in/gyiGdKZy #AI #BioTech #Healthcare #Innovation #NeuralPLexer